Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor. - Montagna, Daniela R.; Duarte, Alejandra; Chiarella, Paula; Rearte, Bárbara; Bustuoabad, Oscar D.; Vermeulen, Mónica; Ruggiero, Raúl A. (BMC Cancer, 2022)